AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif. – Oct. 18, 2017 – AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Harpoon Therapeutics, a biotechnology company developing...
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma – First ACTR Combination Therapy Under Unum’s Collaboration with Seattle Genetics –...
CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies Collaboration expands CRISPR Therapeutics’ efforts in immuno-oncology ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE...
Oxford Immunotec Global PLC Announces Pricing of Underwritten Public Offering of Ordinary Shares OXFORD, United Kingdom and MARLBOROUGH, Mass., August 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company...
Binary Fountain and Kyruus Announce Partnership to Enhance Patient Acquisition and Engagement for Health Systems by Kyruus, on Aug 15, 2017 8:55:42 AM The seamless integration of Binary Star Ratings and Kyruus ProviderMatch for Consumers will enable health systems to...
Recent Comments